APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Management Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nuclear Medicine Management Software Market Outlook and Growth Opportunities 2026

6 January 2026195 pages

Choose your research edition.

Industry ResearchNuclear Medicine Management Software Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Management Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Management Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Management Software Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Management Software Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Management Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nuclear Medicine Management Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nuclear Medicine Management Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Medicine Management Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nuclear Medicine Management Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nuclear Medicine Management Software market include Mirion Technologies, Comecer, ec2 Software Solutions, Esaote, MIM Software, Mediso, Mirada Medical, LabLogic Systems and GE Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nuclear Medicine Management Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nuclear Medicine Management Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nuclear Medicine Management Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nuclear Medicine Management Software market.

Nuclear Medicine Management Software Segment by Company

Mirion Technologies

Comecer

ec2 Software Solutions

Esaote

MIM Software

Mediso

Mirada Medical

LabLogic Systems

GE Healthcare

Mozi Healthcare

Nuclear Medicine Management Software Segment by Type

Radiopharmaceutical Management

Image Data Processing

Others

Nuclear Medicine Management Software Segment by Application

Radiopharmaceutical Management

Image Data Processing

Others

Nuclear Medicine Management Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nuclear Medicine Management Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nuclear Medicine Management Software key companies, revenue, market share, and recent developments.

3. To split the Nuclear Medicine Management Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nuclear Medicine Management Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nuclear Medicine Management Software significant trends, drivers, influence factors in global and regions.

6. To analyze Nuclear Medicine Management Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Management Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Management Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Management Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nuclear Medicine Management Software industry.

Chapter 3: Detailed analysis of Nuclear Medicine Management Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nuclear Medicine Management Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nuclear Medicine Management Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nuclear Medicine Management Software Industry Trends Table 2. Nuclear Medicine Management Software Industry Drivers Table 3. Nuclear Medicine Management Software Industry Opportunities and Challenges Table 4. Nuclear Medicine Management Software Industry Restraints Table 5. Global Nuclear Medicine Management Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nuclear Medicine Management Software Revenue Share by Company (2021-2026) Table 7. Global Nuclear Medicine Management Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nuclear Medicine Management Software Key Company Manufacturing Base & Headquarters Table 9. Global Nuclear Medicine Management Software Company, Product Type & Application Table 10. Global Nuclear Medicine Management Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nuclear Medicine Management Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Radiopharmaceutical Management Table 15. Significant Companies of Image Data Processing Table 16. Significant Companies of Others Table 17. Global Nuclear Medicine Management Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Nuclear Medicine Management Software Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Nuclear Medicine Management Software Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Nuclear Medicine Management Software Sales Value Share by Type (2021-2026) Table 21. Global Nuclear Medicine Management Software Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Radiopharmaceutical Management Table 23. Significant Companies of Image Data Processing Table 24. Significant Companies of Others Table 25. Global Nuclear Medicine Management Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nuclear Medicine Management Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Nuclear Medicine Management Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Nuclear Medicine Management Software Sales Value Share by Application (2021-2026) Table 29. Global Nuclear Medicine Management Software Sales Value Share by Application (2027-2032) Table 30. Global Nuclear Medicine Management Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Nuclear Medicine Management Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Nuclear Medicine Management Software Sales Value Share by Region (2021-2026) Table 33. Global Nuclear Medicine Management Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Nuclear Medicine Management Software Sales Value Share by Region (2027-2032) Table 35. Global Nuclear Medicine Management Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Nuclear Medicine Management Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Nuclear Medicine Management Software Sales Value Market Share by Country (2021-2026) Table 38. Global Nuclear Medicine Management Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Nuclear Medicine Management Software Sales Value Market Share by Country (2027-2032) Table 40. Mirion Technologies Company Information Table 41. Mirion Technologies Business Overview Table 42. Mirion Technologies Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Mirion Technologies Nuclear Medicine Management Software Product Portfolio Table 44. Mirion Technologies Recent Development Table 45. Comecer Company Information Table 46. Comecer Business Overview Table 47. Comecer Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Comecer Nuclear Medicine Management Software Product Portfolio Table 49. Comecer Recent Development Table 50. ec2 Software Solutions Company Information Table 51. ec2 Software Solutions Business Overview Table 52. ec2 Software Solutions Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. ec2 Software Solutions Nuclear Medicine Management Software Product Portfolio Table 54. ec2 Software Solutions Recent Development Table 55. Esaote Company Information Table 56. Esaote Business Overview Table 57. Esaote Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Esaote Nuclear Medicine Management Software Product Portfolio Table 59. Esaote Recent Development Table 60. MIM Software Company Information Table 61. MIM Software Business Overview Table 62. MIM Software Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MIM Software Nuclear Medicine Management Software Product Portfolio Table 64. MIM Software Recent Development Table 65. Mediso Company Information Table 66. Mediso Business Overview Table 67. Mediso Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Mediso Nuclear Medicine Management Software Product Portfolio Table 69. Mediso Recent Development Table 70. Mirada Medical Company Information Table 71. Mirada Medical Business Overview Table 72. Mirada Medical Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Mirada Medical Nuclear Medicine Management Software Product Portfolio Table 74. Mirada Medical Recent Development Table 75. LabLogic Systems Company Information Table 76. LabLogic Systems Business Overview Table 77. LabLogic Systems Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. LabLogic Systems Nuclear Medicine Management Software Product Portfolio Table 79. LabLogic Systems Recent Development Table 80. GE Healthcare Company Information Table 81. GE Healthcare Business Overview Table 82. GE Healthcare Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GE Healthcare Nuclear Medicine Management Software Product Portfolio Table 84. GE Healthcare Recent Development Table 85. Mozi Healthcare Company Information Table 86. Mozi Healthcare Business Overview Table 87. Mozi Healthcare Nuclear Medicine Management Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Mozi Healthcare Nuclear Medicine Management Software Product Portfolio Table 89. Mozi Healthcare Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Nuclear Medicine Management Software Product Image Figure 2. Global Nuclear Medicine Management Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine Management Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Nuclear Medicine Management Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Radiopharmaceutical Management Image Figure 8. Image Data Processing Image Figure 9. Others Image Figure 10. Global Nuclear Medicine Management Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Nuclear Medicine Management Software Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Nuclear Medicine Management Software Sales Value Share by Type (2021-2032) Figure 13. Radiopharmaceutical Management Image Figure 14. Image Data Processing Image Figure 15. Others Image Figure 16. Global Nuclear Medicine Management Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nuclear Medicine Management Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Nuclear Medicine Management Software Sales Value Share by Application (2021-2032) Figure 19. Global Nuclear Medicine Management Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Nuclear Medicine Management Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Nuclear Medicine Management Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Nuclear Medicine Management Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Nuclear Medicine Management Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Nuclear Medicine Management Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Nuclear Medicine Management Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Nuclear Medicine Management Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Nuclear Medicine Management Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Nuclear Medicine Management Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Nuclear Medicine Management Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Nuclear Medicine Management Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Radiopharmaceutical Management
  • Image Data Processing
  • Others
Applications
  • Radiopharmaceutical Management
  • Image Data Processing
  • Others
Companies covered
  • Mirion Technologies
  • Comecer
  • ec2 Software Solutions
  • Esaote
  • MIM Software
  • Mediso
  • Mirada Medical
  • LabLogic Systems
  • GE Healthcare
  • Mozi Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nuclear Medicine Management Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nuclear Medicine Management Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nuclear Medicine Management Software Market Dynamics
  1. 2.1 Nuclear Medicine Management Software Industry Trends
  2. 2.2 Nuclear Medicine Management Software Industry Drivers
  3. 2.3 Nuclear Medicine Management Software Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Management Software Industry Restraints
3 Nuclear Medicine Management Software Market by Company
  1. 3.1 Global Nuclear Medicine Management Software Company Revenue Ranking in 2025
  2. 3.2 Global Nuclear Medicine Management Software Revenue by Company (2021-2026)
  3. 3.3 Global Nuclear Medicine Management Software Company Ranking (2024-2026)
  4. 3.4 Global Nuclear Medicine Management Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Nuclear Medicine Management Software Company Product Type and Application
  6. 3.6 Global Nuclear Medicine Management Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nuclear Medicine Management Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nuclear Medicine Management Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nuclear Medicine Management Software Market by Type
  1. 4.1 Nuclear Medicine Management Software Type Introduction
  2. 4.1.1 Radiopharmaceutical Management
  3. 4.1.2 Image Data Processing
  4. 4.1.3 Others
  5. 4.2 Global Nuclear Medicine Management Software Sales Value by Type
  6. 4.2.1 Global Nuclear Medicine Management Software Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nuclear Medicine Management Software Sales Value by Type (2021-2032)
  8. 4.2.3 Global Nuclear Medicine Management Software Sales Value Share by Type (2021-2032)
5 Nuclear Medicine Management Software Market by Application
  1. 5.1 Nuclear Medicine Management Software Application Introduction
  2. 5.1.1 Radiopharmaceutical Management
  3. 5.1.2 Image Data Processing
  4. 5.1.3 Others
  5. 5.2 Global Nuclear Medicine Management Software Sales Value by Application
  6. 5.2.1 Global Nuclear Medicine Management Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nuclear Medicine Management Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Nuclear Medicine Management Software Sales Value Share by Application (2021-2032)
6 Nuclear Medicine Management Software Regional Value Analysis
  1. 6.1 Global Nuclear Medicine Management Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nuclear Medicine Management Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nuclear Medicine Management Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nuclear Medicine Management Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nuclear Medicine Management Software Sales Value (2021-2032)
  7. 6.3.2 North America Nuclear Medicine Management Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nuclear Medicine Management Software Sales Value (2021-2032)
  10. 6.4.2 Europe Nuclear Medicine Management Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nuclear Medicine Management Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nuclear Medicine Management Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nuclear Medicine Management Software Sales Value (2021-2032)
  16. 6.6.2 South America Nuclear Medicine Management Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nuclear Medicine Management Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nuclear Medicine Management Software Sales Value Share by Country, 2025 VS 2032
7 Nuclear Medicine Management Software Country-level Value Analysis
  1. 7.1 Global Nuclear Medicine Management Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nuclear Medicine Management Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nuclear Medicine Management Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nuclear Medicine Management Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nuclear Medicine Management Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nuclear Medicine Management Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nuclear Medicine Management Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mirion Technologies
  2. 8.1.1 Mirion Technologies Company Information
  3. 8.1.2 Mirion Technologies Business Overview
  4. 8.1.3 Mirion Technologies Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Mirion Technologies Nuclear Medicine Management Software Product Portfolio
  6. 8.1.5 Mirion Technologies Recent Developments
  7. 8.2 Comecer
  8. 8.2.1 Comecer Company Information
  9. 8.2.2 Comecer Business Overview
  10. 8.2.3 Comecer Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Comecer Nuclear Medicine Management Software Product Portfolio
  12. 8.2.5 Comecer Recent Developments
  13. 8.3 ec2 Software Solutions
  14. 8.3.1 ec2 Software Solutions Company Information
  15. 8.3.2 ec2 Software Solutions Business Overview
  16. 8.3.3 ec2 Software Solutions Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ec2 Software Solutions Nuclear Medicine Management Software Product Portfolio
  18. 8.3.5 ec2 Software Solutions Recent Developments
  19. 8.4 Esaote
  20. 8.4.1 Esaote Company Information
  21. 8.4.2 Esaote Business Overview
  22. 8.4.3 Esaote Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Esaote Nuclear Medicine Management Software Product Portfolio
  24. 8.4.5 Esaote Recent Developments
  25. 8.5 MIM Software
  26. 8.5.1 MIM Software Company Information
  27. 8.5.2 MIM Software Business Overview
  28. 8.5.3 MIM Software Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MIM Software Nuclear Medicine Management Software Product Portfolio
  30. 8.5.5 MIM Software Recent Developments
  31. 8.6 Mediso
  32. 8.6.1 Mediso Company Information
  33. 8.6.2 Mediso Business Overview
  34. 8.6.3 Mediso Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mediso Nuclear Medicine Management Software Product Portfolio
  36. 8.6.5 Mediso Recent Developments
  37. 8.7 Mirada Medical
  38. 8.7.1 Mirada Medical Company Information
  39. 8.7.2 Mirada Medical Business Overview
  40. 8.7.3 Mirada Medical Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mirada Medical Nuclear Medicine Management Software Product Portfolio
  42. 8.7.5 Mirada Medical Recent Developments
  43. 8.8 LabLogic Systems
  44. 8.8.1 LabLogic Systems Company Information
  45. 8.8.2 LabLogic Systems Business Overview
  46. 8.8.3 LabLogic Systems Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LabLogic Systems Nuclear Medicine Management Software Product Portfolio
  48. 8.8.5 LabLogic Systems Recent Developments
  49. 8.9 GE Healthcare
  50. 8.9.1 GE Healthcare Company Information
  51. 8.9.2 GE Healthcare Business Overview
  52. 8.9.3 GE Healthcare Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GE Healthcare Nuclear Medicine Management Software Product Portfolio
  54. 8.9.5 GE Healthcare Recent Developments
  55. 8.10 Mozi Healthcare
  56. 8.10.1 Mozi Healthcare Company Information
  57. 8.10.2 Mozi Healthcare Business Overview
  58. 8.10.3 Mozi Healthcare Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mozi Healthcare Nuclear Medicine Management Software Product Portfolio
  60. 8.10.5 Mozi Healthcare Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst